Meanwhile, a recent pilot randomised controlled trial used 100 to 150 IU/d of FSH or human menopausal gonadotropin (HMG) for ovarian stimulation in antagonist cycles with a hCG trigger in women with PCOS (57). Here, BRD2 is linked to polycystic ovary syndrome.